| 0 |
PERISPLENITIS |
1 |
0.5000 |
| 1 |
ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) |
1 |
0.0526 |
| 2 |
SCAN |
1 |
0.0476 |
| 3 |
NON-SMALL CELL LUNG CANCER STAGE III |
1 |
0.0294 |
| 4 |
LUNG SQUAMOUS CELL CARCINOMA STAGE IV |
1 |
0.0149 |
| 5 |
WRONG PRODUCT STORED |
4 |
0.0141 |
| 6 |
DEVICE MALFUNCTION |
915 |
0.0130 |
| 7 |
APPLICATION SITE INDURATION |
2 |
0.0118 |
| 8 |
RHABDOMYOSARCOMA |
2 |
0.0106 |
| 9 |
DEVICE INTOLERANCE |
2 |
0.0084 |
| 10 |
ENDOMETRIAL CANCER RECURRENT |
1 |
0.0076 |
| 11 |
SPLINTER HAEMORRHAGES |
1 |
0.0073 |
| 12 |
GLOMERULAR VASCULAR DISORDER |
1 |
0.0067 |
| 13 |
PRODUCT PACKAGING CONFUSION |
16 |
0.0066 |
| 14 |
PRODUCT LABEL CONFUSION |
36 |
0.0062 |
| 15 |
PAIN MANAGEMENT |
1 |
0.0059 |
| 16 |
EXPULSION OF MEDICATION |
3 |
0.0057 |
| 17 |
ARM AMPUTATION |
1 |
0.0055 |
| 18 |
RADIATION ASSOCIATED PAIN |
1 |
0.0048 |
| 19 |
PRODUCT APPEARANCE CONFUSION |
4 |
0.0043 |
| 20 |
NO ADVERSE EVENT |
715 |
0.0039 |
| 21 |
BLOOD BILIRUBIN DECREASED |
2 |
0.0032 |
| 22 |
METASTASES TO OVARY |
1 |
0.0031 |
| 23 |
DUPLICATE THERAPY ERROR |
1 |
0.0031 |
| 24 |
COLORECTAL ADENOMA |
1 |
0.0031 |
| 25 |
DIVERTICULITIS INTESTINAL PERFORATED |
1 |
0.0028 |
| 26 |
SCAN ABNORMAL |
1 |
0.0027 |
| 27 |
BONE MARROW INFILTRATION |
1 |
0.0026 |
| 28 |
DRUG DELIVERY SYSTEM ISSUE |
5 |
0.0025 |
| 29 |
PRODUCT CONFUSION |
2 |
0.0025 |
| 30 |
DEVICE FAILURE |
38 |
0.0025 |
| 31 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 32 |
FIBROADENOMA OF BREAST |
1 |
0.0022 |
| 33 |
INTERCEPTED PRODUCT DISPENSING ERROR |
3 |
0.0018 |
| 34 |
MEDICAL DEVICE SITE PAIN |
1 |
0.0018 |
| 35 |
DEVICE INFUSION ISSUE |
4 |
0.0016 |
| 36 |
AORTITIS |
1 |
0.0015 |
| 37 |
NEUROENDOCRINE CARCINOMA |
1 |
0.0014 |
| 38 |
SMALL CELL LUNG CANCER |
2 |
0.0013 |
| 39 |
MALIGNANT ASCITES |
1 |
0.0013 |
| 40 |
PSEUDOMONAS TEST POSITIVE |
1 |
0.0012 |
| 41 |
CONGENITAL CARDIOVASCULAR ANOMALY |
1 |
0.0012 |
| 42 |
TREATMENT DELAYED |
2 |
0.0012 |
| 43 |
INTRA-ABDOMINAL FLUID COLLECTION |
2 |
0.0011 |
| 44 |
MUSCLE NECROSIS |
1 |
0.0011 |
| 45 |
BLOOD URINE |
1 |
0.0010 |
| 46 |
APPLICATION SITE BRUISE |
1 |
0.0010 |
| 47 |
HYPOCHROMIC ANAEMIA |
1 |
0.0010 |
| 48 |
BREAST NEOPLASM |
1 |
0.0010 |
| 49 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 50 |
INTERCEPTED MEDICATION ERROR |
4 |
0.0009 |
| 51 |
TONGUE HAEMORRHAGE |
1 |
0.0009 |
| 52 |
FULL BLOOD COUNT INCREASED |
1 |
0.0008 |
| 53 |
INTRADUCTAL PROLIFERATIVE BREAST LESION |
1 |
0.0008 |
| 54 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 55 |
OBSTRUCTION GASTRIC |
1 |
0.0008 |
| 56 |
INTERCEPTED PRODUCT SELECTION ERROR |
1 |
0.0008 |
| 57 |
SYRINGE ISSUE |
13 |
0.0007 |
| 58 |
NEUTROPHIL COUNT DECREASED |
30 |
0.0007 |
| 59 |
DRUG SPECIFIC ANTIBODY |
1 |
0.0007 |
| 60 |
PANCREATIC CARCINOMA METASTATIC |
2 |
0.0007 |
| 61 |
MALIGNANT PLEURAL EFFUSION |
1 |
0.0006 |
| 62 |
WRONG PRODUCT ADMINISTERED |
4 |
0.0006 |
| 63 |
SPLENIC INFARCTION |
1 |
0.0006 |
| 64 |
MASTECTOMY |
1 |
0.0006 |
| 65 |
DEVICE LEAKAGE |
24 |
0.0006 |
| 66 |
PRODUCT DOSE OMISSION ISSUE |
159 |
0.0005 |
| 67 |
PRODUCT LEAKAGE |
3 |
0.0005 |
| 68 |
CHEMOTHERAPY |
2 |
0.0005 |
| 69 |
NEEDLE ISSUE |
15 |
0.0005 |
| 70 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
13 |
0.0005 |
| 71 |
APPLICATION SITE DISCOLOURATION |
2 |
0.0005 |
| 72 |
NEUTROPENIC COLITIS |
1 |
0.0005 |
| 73 |
EYE CONTUSION |
1 |
0.0005 |
| 74 |
METASTATIC NEOPLASM |
2 |
0.0005 |
| 75 |
DEVICE ADHESION ISSUE |
7 |
0.0005 |
| 76 |
ENDOMETRIAL CANCER |
1 |
0.0005 |
| 77 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 78 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 79 |
NEUTROPENIC SEPSIS |
3 |
0.0004 |
| 80 |
URINE FLOW DECREASED |
1 |
0.0004 |
| 81 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 82 |
APPLICATION SITE SWELLING |
2 |
0.0004 |
| 83 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 84 |
INJURY ASSOCIATED WITH DEVICE |
8 |
0.0004 |
| 85 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 86 |
ACCIDENTAL EXPOSURE TO PRODUCT |
39 |
0.0004 |
| 87 |
INVASIVE DUCTAL BREAST CARCINOMA |
1 |
0.0004 |
| 88 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 89 |
BONE PAIN |
21 |
0.0004 |
| 90 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
0.0004 |
| 91 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 92 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 93 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
2 |
0.0003 |
| 94 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
1 |
0.0003 |
| 95 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 96 |
FULL BLOOD COUNT ABNORMAL |
3 |
0.0003 |
| 97 |
APPENDICECTOMY |
1 |
0.0003 |
| 98 |
DEVICE USE ERROR |
9 |
0.0003 |
| 99 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 100 |
OBSTRUCTION |
1 |
0.0003 |
| 101 |
ORGAN FAILURE |
1 |
0.0002 |
| 102 |
HYPERURICAEMIA |
1 |
0.0002 |
| 103 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 104 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 105 |
DEVICE USE ISSUE |
4 |
0.0002 |
| 106 |
APPLICATION SITE PAIN |
5 |
0.0002 |
| 107 |
FEBRILE NEUTROPENIA |
15 |
0.0002 |
| 108 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 109 |
DISEASE COMPLICATION |
1 |
0.0002 |
| 110 |
GASTRITIS EROSIVE |
1 |
0.0002 |
| 111 |
SKIN ABRASION |
1 |
0.0002 |
| 112 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 113 |
INSURANCE ISSUE |
3 |
0.0002 |
| 114 |
CACHEXIA |
1 |
0.0002 |
| 115 |
TRISMUS |
1 |
0.0002 |
| 116 |
EXPOSURE VIA SKIN CONTACT |
5 |
0.0002 |
| 117 |
SKIN NECROSIS |
1 |
0.0002 |
| 118 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 119 |
DEVICE ISSUE |
17 |
0.0002 |
| 120 |
HIP SURGERY |
1 |
0.0002 |
| 121 |
PRODUCT DISPENSING ERROR |
4 |
0.0002 |
| 122 |
DEVICE DELIVERY SYSTEM ISSUE |
5 |
0.0002 |
| 123 |
WHITE BLOOD CELL COUNT INCREASED |
7 |
0.0002 |
| 124 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 125 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 126 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 127 |
WHITE BLOOD CELL COUNT DECREASED |
19 |
0.0002 |
| 128 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
8 |
0.0002 |
| 129 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 130 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 131 |
TREATMENT NONCOMPLIANCE |
9 |
0.0002 |
| 132 |
DEVICE DISLOCATION |
7 |
0.0002 |
| 133 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 134 |
INCOHERENT |
1 |
0.0002 |
| 135 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 136 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 137 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 138 |
PAIN IN JAW |
4 |
0.0001 |
| 139 |
DIVERTICULUM |
1 |
0.0001 |
| 140 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 141 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 142 |
TROPONIN INCREASED |
1 |
0.0001 |
| 143 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 144 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 145 |
APHTHOUS ULCER |
1 |
0.0001 |
| 146 |
DEVICE INFORMATION OUTPUT ISSUE |
1 |
0.0001 |
| 147 |
ULCER |
2 |
0.0001 |
| 148 |
GINGIVAL PAIN |
1 |
0.0001 |
| 149 |
PRODUCT QUALITY ISSUE |
17 |
0.0001 |
| 150 |
CANDIDA INFECTION |
2 |
0.0001 |
| 151 |
NEUTROPENIA |
16 |
0.0001 |
| 152 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 153 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 154 |
DEATH |
99 |
0.0001 |
| 155 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 156 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 157 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 158 |
PNEUMONITIS |
3 |
0.0001 |
| 159 |
OVARIAN CANCER |
1 |
0.0001 |
| 160 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 161 |
NEOPLASM MALIGNANT |
7 |
0.0001 |
| 162 |
HOSPITALISATION |
16 |
0.0001 |
| 163 |
PANCREATIC CARCINOMA |
3 |
0.0001 |
| 164 |
INTENTIONAL PRODUCT USE ISSUE |
9 |
0.0001 |
| 165 |
THERAPY CHANGE |
1 |
0.0001 |
| 166 |
HOSPICE CARE |
1 |
0.0001 |
| 167 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 168 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 169 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 170 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 171 |
TENDERNESS |
1 |
0.0001 |
| 172 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 173 |
BREAST PAIN |
1 |
0.0001 |
| 174 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 175 |
SEPTIC SHOCK |
4 |
0.0001 |
| 176 |
OESOPHAGITIS |
1 |
0.0001 |
| 177 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 178 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 179 |
SPLENOMEGALY |
1 |
0.0001 |
| 180 |
SPINAL PAIN |
1 |
0.0001 |
| 181 |
THERAPY INTERRUPTED |
6 |
0.0001 |
| 182 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 183 |
ILEUS |
1 |
0.0001 |
| 184 |
CELLULITIS |
4 |
0.0001 |
| 185 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 186 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 187 |
TOOTH INFECTION |
1 |
0.0001 |
| 188 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 189 |
PLATELET COUNT DECREASED |
8 |
0.0001 |
| 190 |
JAUNDICE |
2 |
0.0001 |
| 191 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 192 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 193 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 194 |
PRODUCT STORAGE ERROR |
6 |
0.0001 |
| 195 |
PULMONARY MASS |
1 |
0.0001 |
| 196 |
COLON CANCER |
1 |
0.0001 |
| 197 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 198 |
STOMATITIS |
4 |
0.0001 |
| 199 |
THYROID DISORDER |
1 |
0.0001 |
| 200 |
ABSCESS |
1 |
0.0001 |
| 201 |
METASTASES TO BONE |
1 |
0.0001 |
| 202 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 203 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 204 |
BURNING SENSATION |
4 |
0.0001 |
| 205 |
INCORRECT DOSE ADMINISTERED |
13 |
0.0001 |
| 206 |
METASTASES TO LIVER |
1 |
0.0001 |
| 207 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 208 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 209 |
SEPSIS |
6 |
0.0001 |
| 210 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 211 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 212 |
DYSARTHRIA |
2 |
0.0001 |
| 213 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 214 |
COLITIS |
2 |
0.0001 |
| 215 |
FOOT FRACTURE |
1 |
0.0001 |
| 216 |
GASTRIC ULCER |
1 |
0.0001 |
| 217 |
DEHYDRATION |
7 |
0.0001 |
| 218 |
DYSPHONIA |
3 |
0.0001 |
| 219 |
CHOKING |
1 |
0.0001 |
| 220 |
SKIN FISSURES |
1 |
0.0001 |
| 221 |
HEART RATE INCREASED |
5 |
0.0001 |
| 222 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 223 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 224 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 225 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
9 |
0.0000 |
| 226 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 227 |
THROMBOSIS |
4 |
0.0000 |
| 228 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 229 |
TASTE DISORDER |
1 |
0.0000 |
| 230 |
FLUSHING |
5 |
0.0000 |
| 231 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 232 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 233 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 234 |
BACK PAIN |
11 |
0.0000 |
| 235 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 236 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 237 |
ORAL PAIN |
1 |
0.0000 |
| 238 |
SNEEZING |
1 |
0.0000 |
| 239 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 240 |
CHEST PAIN |
8 |
0.0000 |
| 241 |
ARRHYTHMIA |
2 |
0.0000 |
| 242 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 243 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 244 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 245 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 246 |
PRESYNCOPE |
1 |
0.0000 |
| 247 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 248 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 249 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 250 |
RASH GENERALISED |
1 |
0.0000 |
| 251 |
MUSCLE SPASMS |
7 |
0.0000 |
| 252 |
JOINT STIFFNESS |
1 |
0.0000 |
| 253 |
EAR INFECTION |
1 |
0.0000 |
| 254 |
PYREXIA |
13 |
0.0000 |
| 255 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 256 |
PALLOR |
1 |
0.0000 |
| 257 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 258 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 259 |
HAEMOPTYSIS |
1 |
0.0000 |
| 260 |
NECK PAIN |
2 |
0.0000 |
| 261 |
EYE PAIN |
2 |
0.0000 |
| 262 |
HYPERSOMNIA |
1 |
0.0000 |
| 263 |
LETHARGY |
2 |
0.0000 |
| 264 |
INFECTION |
5 |
0.0000 |
| 265 |
DYSSTASIA |
1 |
0.0000 |
| 266 |
SURGERY |
2 |
0.0000 |
| 267 |
NASAL CONGESTION |
2 |
0.0000 |
| 268 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 269 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 270 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 271 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 272 |
CYSTITIS |
1 |
0.0000 |
| 273 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 274 |
HYPERHIDROSIS |
4 |
0.0000 |
| 275 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 276 |
SWELLING FACE |
2 |
0.0000 |
| 277 |
CHOLELITHIASIS |
1 |
0.0000 |
| 278 |
IMPAIRED HEALING |
1 |
0.0000 |
| 279 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 280 |
LIP SWELLING |
1 |
0.0000 |
| 281 |
FUNGAL INFECTION |
1 |
0.0000 |
| 282 |
VOMITING |
14 |
0.0000 |
| 283 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 284 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 285 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 286 |
ILLNESS |
3 |
0.0000 |
| 287 |
NIGHTMARE |
1 |
0.0000 |
| 288 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 289 |
MOBILITY DECREASED |
2 |
0.0000 |
| 290 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 291 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 292 |
DYSURIA |
1 |
0.0000 |
| 293 |
INJECTION SITE MASS |
1 |
0.0000 |
| 294 |
EPISTAXIS |
2 |
0.0000 |
| 295 |
DYSPNOEA |
15 |
0.0000 |
| 296 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 297 |
ALOPECIA |
5 |
0.0000 |
| 298 |
NAUSEA |
20 |
0.0000 |
| 299 |
BLINDNESS |
1 |
0.0000 |
| 300 |
PAIN |
15 |
0.0000 |
| 301 |
TREATMENT FAILURE |
2 |
0.0000 |
| 302 |
TREMOR |
4 |
0.0000 |
| 303 |
POLLAKIURIA |
1 |
0.0000 |
| 304 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 305 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 306 |
URTICARIA |
4 |
0.0000 |
| 307 |
CONSTIPATION |
5 |
0.0000 |
| 308 |
MALAISE |
10 |
0.0000 |
| 309 |
COVID-19 |
4 |
0.0000 |
| 310 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 311 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 312 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 313 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 314 |
DECREASED APPETITE |
5 |
0.0000 |
| 315 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 316 |
SWELLING |
2 |
0.0000 |
| 317 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 318 |
ASTHENIA |
8 |
0.0000 |
| 319 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 320 |
FEELING ABNORMAL |
5 |
0.0000 |
| 321 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 322 |
HEADACHE |
13 |
0.0000 |
| 323 |
SYNCOPE |
2 |
0.0000 |
| 324 |
HYPOTENSION |
4 |
0.0000 |
| 325 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 326 |
SINUSITIS |
2 |
0.0000 |
| 327 |
THERAPY CESSATION |
1 |
0.0000 |
| 328 |
BRADYCARDIA |
1 |
0.0000 |
| 329 |
DIARRHOEA |
12 |
0.0000 |
| 330 |
OEDEMA |
1 |
0.0000 |
| 331 |
RASH |
8 |
0.0000 |
| 332 |
INFLUENZA |
2 |
0.0000 |
| 333 |
PANCYTOPENIA |
1 |
0.0000 |
| 334 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 335 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 336 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 337 |
MYALGIA |
3 |
0.0000 |
| 338 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 339 |
HERPES ZOSTER |
1 |
0.0000 |
| 340 |
SEIZURE |
2 |
0.0000 |
| 341 |
OFF LABEL USE |
15 |
0.0000 |
| 342 |
FEELING HOT |
1 |
0.0000 |
| 343 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 344 |
ANAEMIA |
3 |
0.0000 |
| 345 |
PNEUMONIA |
5 |
0.0000 |
| 346 |
FATIGUE |
12 |
0.0000 |
| 347 |
AMNESIA |
1 |
0.0000 |
| 348 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 349 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 350 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 351 |
FALL |
5 |
0.0000 |
| 352 |
ANXIETY |
4 |
0.0000 |
| 353 |
BRONCHITIS |
1 |
0.0000 |
| 354 |
HYPOAESTHESIA |
2 |
0.0000 |
| 355 |
DEPRESSION |
3 |
0.0000 |
| 356 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 357 |
DIABETES MELLITUS |
1 |
0.0000 |
| 358 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 359 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 360 |
PRURITUS |
5 |
0.0000 |
| 361 |
PARAESTHESIA |
2 |
0.0000 |
| 362 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 363 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 364 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 365 |
CARDIAC ARREST |
1 |
0.0000 |
| 366 |
ARTHRALGIA |
5 |
0.0000 |
| 367 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 368 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 369 |
DRUG INEFFECTIVE |
15 |
0.0000 |
| 370 |
INSOMNIA |
3 |
0.0000 |
| 371 |
TACHYCARDIA |
1 |
0.0000 |
| 372 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 373 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 374 |
ADVERSE EVENT |
1 |
0.0000 |
| 375 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 376 |
WEIGHT DECREASED |
3 |
0.0000 |
| 377 |
COUGH |
3 |
0.0000 |
| 378 |
DYSPHAGIA |
1 |
0.0000 |
| 379 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 380 |
MIGRAINE |
1 |
0.0000 |
| 381 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 382 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 383 |
ERYTHEMA |
2 |
0.0000 |
| 384 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 385 |
HAEMORRHAGE |
1 |
0.0000 |
| 386 |
OVERDOSE |
2 |
0.0000 |
| 387 |
ASTHMA |
1 |
0.0000 |
| 388 |
PALPITATIONS |
1 |
0.0000 |
| 389 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 390 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 391 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 392 |
RENAL FAILURE |
1 |
0.0000 |
| 393 |
DRY SKIN |
1 |
0.0000 |
| 394 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 395 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 396 |
DRUG INTERACTION |
1 |
0.0000 |
| 397 |
DIZZINESS |
3 |
0.0000 |
| 398 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 399 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 400 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 401 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 402 |
SOMNOLENCE |
1 |
0.0000 |
| 403 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |